US - Catalent To Be Acquired By Novo Holdings. - Conventus Law

February 16, 2024 by Rohin Pujari

Skadden is representing contract drug manufacturer Catalent, Inc. in its $16.5 billion acquisition by Novo Holdings A/S.

Register for your monthly Asia legal updates from Conventus Law

Error: Contact form not found.